Business Context and Reporting Period
This Form 8-K, dated December 14, 2023, is filed by Chavant Capital Acquisition Corp. (Chavant) regarding its proposed business combination with Mobix Labs, Inc. The filing reports on an extraordinary general meeting held on December 14, 2023, where shareholders voted to adjourn the special meeting originally scheduled to approve the merger. The combined entity is intended to be named Mobix Labs, Inc.
Key Financial Metrics and Liquidity
The filing does not provide specific revenue, profit, or cash flow figures for Mobix Labs or Chavant. However, it discloses the following liquidity and transaction-related data:
- Redemptions: As of December 12, 2023, 751,167 ordinary shares of Chavant were redeemed for a pro rata portion of the trust account funds.
- Minimum Cash Condition: Chavant believes it will not be able to satisfy the Minimum Cash Condition required to close the transaction on the initial date.
- Financing Status: Chavant, Mobix Labs, and the PIPE Investor are actively seeking additional financing to allow Mobix Labs to potentially waive the Minimum Cash Condition.
Material Changes and Voting Results
The primary material event is the adjournment of the shareholder vote on the Proposed Transaction. At the meeting on December 14, 2023:
- Quorum: 2,338,773 ordinary shares (approximately 84.16% of voting shares) were present.
- Voting Results on Adjournment Proposal:
- For: 2,496,408 votes
- Against: 3,004 votes
- Abstain: 0 votes
- Outcome: The Special Meeting was adjourned without further business and will reconvene on December 18, 2023, at 1:00 p.m. Eastern time.
- Redemption Deadline: The deadline for exercising redemption rights was extended to 5:00 p.m. Eastern time on December 14, 2023.
Outlook, Risks, and Management Commentary
Management is focused on securing additional financing to meet the Minimum Cash Condition or obtaining a waiver from Mobix Labs. The filing highlights significant risks, including:
- Transaction Completion: Risk that the transaction may not be completed in a timely manner or at all.
- Capital Requirements: Risk that Mobix Labs may need to raise additional capital to execute its business plan, which may not be available on acceptable terms.
- Profitability: Risk that Mobix Labs may never achieve or sustain profitability.
- Commercialization: Risk of delays in commercializing semiconductor products and solutions.
- Market and Regulatory: Risks related to U.S./China trade tensions, 5G technology transitions, and Nasdaq listing requirements.
Investor Verification Checklist
- Verify the status of the additional financing efforts and whether the Minimum Cash Condition has been satisfied or waived prior to the reconvened meeting on December 18, 2023.
- Review the updated redemption numbers after the extended deadline of December 14, 2023, to assess the final cash position of the trust.
- Confirm the terms and commitment status of the PIPE (Private Investment in Public Equity) investors.
- Monitor for any further amendments to the Business Combination Agreement or the Proxy Statement/Prospectus.
- Assess the impact of the adjournment on the company's ability to meet Nasdaq listing requirements.